Xeno Biosciences' Unattributed Round

Xeno Biosciences raised a round of funding on August 03, 2018.

Xeno is a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed t…

Articles about Xeno Biosciences' Unattributed Round: